160 related articles for article (PubMed ID: 35976137)
1. Genetic signature of differentiated thyroid carcinoma susceptibility: a machine learning approach.
Brigante G; Lazzaretti C; Paradiso E; Nuzzo F; Sitti M; Tüttelmann F; Moretti G; Silvestri R; Gemignani F; Försti A; Hemminki K; Elisei R; Romei C; Zizzi EA; Deriu MA; Simoni M; Landi S; Casarini L
Eur Thyroid J; 2022 Oct; 11(5):. PubMed ID: 35976137
[TBL] [Abstract][Full Text] [Related]
2. Novel genome-wide association study-based candidate loci for differentiated thyroid cancer risk.
Figlioli G; Köhler A; Chen B; Elisei R; Romei C; Cipollini M; Cristaudo A; Bambi F; Paolicchi E; Hoffmann P; Herms S; Kalemba M; Kula D; Pastor S; Marcos R; Velázquez A; Jarząb B; Landi S; Hemminki K; Försti A; Gemignani F
J Clin Endocrinol Metab; 2014 Oct; 99(10):E2084-92. PubMed ID: 25029422
[TBL] [Abstract][Full Text] [Related]
3. Robust SNP-based prediction of rheumatoid arthritis through machine-learning-optimized polygenic risk score.
Lim AJW; Tyniana CT; Lim LJ; Tan JWL; Koh ET; ; Chong SS; Khor CC; Leong KP; Lee CG
J Transl Med; 2023 Feb; 21(1):92. PubMed ID: 36750873
[TBL] [Abstract][Full Text] [Related]
4. Clinical implications of GWAS variants associated with differentiated thyroid cancer.
Jendrzejewski JP; Sworczak K; Comiskey DF; de la Chapelle A
Endokrynol Pol; 2019; 70(5):423-429. PubMed ID: 31681970
[TBL] [Abstract][Full Text] [Related]
5. Fine-mapping of two differentiated thyroid carcinoma susceptibility loci at 9q22.33 and 14q13.3 detects novel candidate functional SNPs in Europeans from metropolitan France and Melanesians from New Caledonia.
Tcheandjieu C; Lesueur F; Sanchez M; Baron-Dubourdieu D; Guizard AV; Mulot C; Laurent-Puig P; Schvartz C; Truong T; Guenel P
Int J Cancer; 2016 Aug; 139(3):617-27. PubMed ID: 26991144
[TBL] [Abstract][Full Text] [Related]
6. Validating and automating learning of cardiometabolic polygenic risk scores from direct-to-consumer genetic and phenotypic data: implications for scaling precision health research.
Lopez-Pineda A; Vernekar M; Moreno-Grau S; Rojas-Muñoz A; Moatamed B; Lee MTM; Nava-Aguilar MA; Gonzalez-Arroyo G; Numakura K; Matsuda Y; Ioannidis A; Katsanis N; Takano T; Bustamante CD
Hum Genomics; 2022 Sep; 16(1):37. PubMed ID: 36076307
[TBL] [Abstract][Full Text] [Related]
7. The role of CCNH Val270Ala (rs2230641) and other nucleotide excision repair polymorphisms in individual susceptibility to well-differentiated thyroid cancer.
Santos LS; Gomes BC; Gouveia R; Silva SN; Azevedo AP; Camacho V; Manita I; Gil OM; Ferreira TC; Limbert E; Rueff J; Gaspar JF
Oncol Rep; 2013 Nov; 30(5):2458-66. PubMed ID: 23982724
[TBL] [Abstract][Full Text] [Related]
8. TPO genetic variants and risk of differentiated thyroid carcinoma in two European populations.
Cipollini M; Pastor S; Gemignani F; Castell J; Garritano S; Bonotti A; Biarnés J; Figlioli G; Romei C; Marcos R; Cristaudo A; Elisei R; Landi S; Velázquez A
Int J Cancer; 2013 Dec; 133(12):2843-51. PubMed ID: 23754668
[TBL] [Abstract][Full Text] [Related]
9. Association Studies Between XRCC1, XRCC2, XRCC3 Polymorphisms and Differentiated Thyroid Carcinoma.
Yan L; Li Q; Li X; Ji H; Zhang L
Cell Physiol Biochem; 2016; 38(3):1075-84. PubMed ID: 26938431
[TBL] [Abstract][Full Text] [Related]
10. Novel genetic variants in differentiated thyroid cancer and assessment of the cumulative risk.
Figlioli G; Chen B; Elisei R; Romei C; Campo C; Cipollini M; Cristaudo A; Bambi F; Paolicchi E; Hoffmann P; Herms S; Kalemba M; Kula D; Pastor S; Marcos R; Velázquez A; Jarząb B; Landi S; Hemminki K; Gemignani F; Försti A
Sci Rep; 2015 Mar; 5():8922. PubMed ID: 25753578
[TBL] [Abstract][Full Text] [Related]
11. A Comprehensive Meta-analysis of Case-Control Association Studies to Evaluate Polymorphisms Associated with the Risk of Differentiated Thyroid Carcinoma.
Figlioli G; Elisei R; Romei C; Melaiu O; Cipollini M; Bambi F; Chen B; Köhler A; Cristaudo A; Hemminki K; Gemignani F; Försti A; Landi S
Cancer Epidemiol Biomarkers Prev; 2016 Apr; 25(4):700-13. PubMed ID: 26843521
[TBL] [Abstract][Full Text] [Related]
12. Common variants of the thyroglobulin gene are associated with differentiated thyroid cancer risk.
Akdi A; Pérez G; Pastor S; Castell J; Biarnés J; Marcos R; Velázquez A
Thyroid; 2011 May; 21(5):519-25. PubMed ID: 21476894
[TBL] [Abstract][Full Text] [Related]
13. Prediction of gastric cancer risk by a polygenic risk score of
Wang XY; Wang LL; Liang SZ; Yang C; Xu L; Yu MC; Wang YX; Dong QJ
World J Gastrointest Oncol; 2022 Sep; 14(9):1844-1855. PubMed ID: 36187384
[TBL] [Abstract][Full Text] [Related]
14. Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinoma.
Pellé L; Cipollini M; Tremmel R; Romei C; Figlioli G; Gemignani F; Melaiu O; De Santi C; Barone E; Elisei R; Seiser E; Innocenti F; Zanger UM; Landi S
Arch Toxicol; 2016 Dec; 90(12):3099-3109. PubMed ID: 26783003
[TBL] [Abstract][Full Text] [Related]
15. Association of XRCC1 polymorphisms and risk of differentiated thyroid carcinoma: a case-control analysis.
Ho T; Li G; Lu J; Zhao C; Wei Q; Sturgis EM
Thyroid; 2009 Feb; 19(2):129-35. PubMed ID: 19191745
[TBL] [Abstract][Full Text] [Related]
16. Genetic factors for differentiated thyroid cancer in French Polynesia: new candidate loci.
Zidane M; Haber M; Truong T; Rachédi F; Ory C; Chevillard S; Blanché H; Olaso R; Boland A; Conte É; Karimi M; Ren Y; Xhaard C; Souchard V; Gardon J; Taquet M; Bouville A; Deleuze JF; Drozdovitch V; de Vathaire F; Cazier JB
Precis Clin Med; 2023 Jun; 6(2):pbad015. PubMed ID: 37383672
[TBL] [Abstract][Full Text] [Related]
17. Significance of MDM2 and P14 ARF polymorphisms in susceptibility to differentiated thyroid carcinoma.
Zhang F; Xu L; Wei Q; Song X; Sturgis EM; Li G
Surgery; 2013 May; 153(5):711-7. PubMed ID: 23218882
[TBL] [Abstract][Full Text] [Related]
18. Fine-mapping of two differentiated thyroid carcinoma susceptibility loci at 2q35 and 8p12 in Europeans, Melanesians and Polynesians.
Guibon J; Sugier PE; Kulkarni O; Karimi M; Bacq-Daian D; Besse C; Boland A; Adjadj E; Rachédi F; Rubino C; Xhaard C; Mulot C; Laurent-Puig P; Guizard AV; Schvartz C; Ortiz RM; Ren Y; Ostroumova E; Deleuze JF; Boutron-Ruault MC; Kesminiene A; De Vathaire F; Guénel P; Lesueur F; Truong T
Oncotarget; 2021 Mar; 12(5):493-506. PubMed ID: 33747362
[TBL] [Abstract][Full Text] [Related]
19. Association of BRCA1 functional single nucleotide polymorphisms with risk of differentiated thyroid carcinoma.
Xu L; Doan PC; Wei Q; Liu Y; Li G; Sturgis EM
Thyroid; 2012 Jan; 22(1):35-43. PubMed ID: 22136207
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of genome-wide polygenic risk scores for predicting breast cancer incidence in Japanese females: a population-based case-cohort study.
Ohbe H; Hachiya T; Yamaji T; Nakano S; Miyamoto Y; Sutoh Y; Otsuka-Yamasaki Y; Shimizu A; Yasunaga H; Sawada N; Inoue M; Tsugane S; Iwasaki M;
Breast Cancer Res Treat; 2023 Feb; 197(3):661-671. PubMed ID: 36538246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
